Agenda
Emerging companies find it increasingly difficult to reach the right person when seeking funding and/or partners. Through the �Meet with�� Series, we provide emerging companies with greater access to partnering and/or financing opportunities.
In this session, Directors from
Physic Ventures will explain what they are looking for in a company.
After the presentation,
each pre-approved attendee will be granted a private meeting with Director
Stacey Feld or
Andrew Williamson.
Registrations are subject to approval of application.
About Physic Ventures
Physic Ventures, based in San Francisco, provides capital and support to entrepreneurs focused on building exceptional science-based, consumer-directed health and sustainable living companies. Our strategy is to capitalize on major economic, social and political trends shaping the landscape of personal and planetary health, including the rapid migration toward a consumer-driven, prevention-oriented "self-care" paradigm.
Speakers Bios
Stacy Feld, Director, Physic Ventures
Stacy Feld is a Director at Physic Ventures. Stacy focuses on personalized health solutions to improve and transform care for the health consumer. Specifically, Stacy is interested in life science opportunities offering more precise prevention, diagnosis, and treatment of chronic disease. Stacy brings to Physic over ten years of transactional experience in the life science and healthcare industries. Prior to joining Physic, Stacy was Associate Director of Business Development at Genentech, Inc., where she focused on sourcing and accessing novel therapies and predictive diagnostics in the areas of Oncology, Immunology, Ophthalmology, Vascular Biology and Metabolic Diseases. While at Genentech, she worked to establish multiple disease area strategies for the company and led collaboration teams for the evaluation and execution of strategic partnerships and licensing arrangements. Formerly, Stacy was Director of Licensing and Corporate Development at Third Wave Technologies, Inc., a molecular diagnostics company (since acquired by Hologic, Inc. in2008), where she was responsible for in-licensing intellectual property to support product development and building strategic relationships with customers, collaborators and suppliers. Stacy began her career in life sciences as an Associate at Wilson Sonsini Goodrich and Rosati in Palo Alto, CA. As an attorney in the firm's Technology Transactions practice, she advised start-ups and mature companies in the biopharmaceutical and medical device sectors on intellectual property matters and strategic business transactions. Stacy received a B.A. in Sociology, graduating magna cum laude from the University of Pennsylvania and earned her J.D. from Vanderbilt Law School.
Andrew Williamson, Director, Physic Ventures
Andrew Williamson is a Director at Physic Ventures. Since joining early in 2007, Andrew has focused on working with companies that are developing products and technologies to enable consumers to adopt more sustainable lifestyles. Among the portfolio company investments managed by Physic Ventures, Andrew is on the boards of Chromatin, EnergyHub, Halosource, Impinj and Novomer. Prior to joining Physic Ventures, Andrew spent 10 years leading materials science research and development projects at the Department of Energy's National Renewable Energy Laboratory (NREL) and Lawrence Livermore National Laboratory. At NREL, Andrew developed computational models for predicting the opto-electronic properties of next generation photovoltaic materials. At LLNL, Andrew was the project leader for computational nanomaterials research. His group's research activities included nanomaterials, hydrogen storage, thermoelectric materials and battery technology. Andrew also helped LLNL develop strategies for identifying and commercializing new technologies. He represented LLNL as an Executive Management Fellow in the University of California Industry-University Cooperative Research Program to establish industrial alliance programs for new University of California research centers in nanotechnology, micro-fluidics, foods for health, and stem cell research. Andrew has published over 50 peer reviewed academic articles and 2 patents. He holds a BA and a Ph.D. in Physics from the University of Cambridge and a MBA from the Haas School of Business at the University of California, Berkeley.
